SKI Market

A+| A| A-|

Indian Indices

Sensex

77,763.91 261.79
( 0.34%)

Global Indices

Nasdaq

52,921.07 594.83
(1.14%)

Dow Jones

7,504.24 0.01
(0.00%)

Hang Seng

69,733.68 1,000.53
(1.46%)

Nikkei 225

10,673.34 20.47
(0.19%)

Forex

USD-INR

95.28 0.28
(0.30%)

EUR-INR

108.75 0.54
(0.50%)

GBP-INR

126.99 1.06
(0.84%)

JPY-INR

0.59 0.01
(0.97%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

37.78

72.59

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

radhagobind commercial ltd

Radico Khaitan consolidated net profit rises 94.92% in the March 2026 quarter

May 06,2026

Net profit of Radico Khaitan rose 94.92% to Rs 179.46 crore in the quarter ended March 2026 as against Rs 92.07 crore during the previous quarter ended March 2025. Sales rose 15.31% to Rs 1503.71 crore in the quarter ended March 2026 as against Rs 1304.08 crore during the previous quarter ended March 2025.

For the full year,net profit rose 74.90% to Rs 604.48 crore in the year ended March 2026 as against Rs 345.61 crore during the previous year ended March 2025. Sales rose 24.72% to Rs 6050.43 crore in the year ended March 2026 as against Rs 4851.15 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	1503.71	1304.08	15	6050.43	4851.15	25
OPM %	18.92	13.61	-	16.88	13.89	-
PBDT	279.22	158.85	76	974.81	605.18	61
PBT	237.02	122.87	93	821.78	465.04	77
NP	179.46	92.07	95	604.48	345.61	75

77,763.91 261.79 ( 0.34%)

52,921.07 594.83 (1.14%)

7,504.24 0.01 (0.00%)

69,733.68 1,000.53 (1.46%)

10,673.34 20.47 (0.19%)

95.28 0.28 (0.30%)

108.75 0.54 (0.50%)

126.99 1.06 (0.84%)

0.59 0.01 (0.97%)